Role of adenovirus type 11 in hemorrhagic cystitis secondary to immunosuppression.
D000256:Adenoviridae / Q000276:immunology / Q000302:isolation & purification*; D000914:Antibodies, Viral; D001379:Azathioprine / Q000009:adverse effects / Q000627:therapeutic use; D003168:Complement Fixation Tests; D003520:Cyclophosphamide / Q000627:therapeutic use; D003556:Cystitis / Q000139:chemically induced / Q000209:etiology / Q000276:immunology / Q000382:microbiology*; D005260:Female; D006084:Graft Rejection; D006470:Hemorrhage / Q000139:chemically induced / Q000209:etiology / Q000276:immunology / Q000382:microbiology*; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects*; D016030:Kidney Transplantation; D008875:Middle Aged; D009500:Neutralization Tests; D011241:Prednisone / Q000009:adverse effects / Q000627:therapeutic use; D014184:Transplantation, Homologous
D000914:Antibodies, Viral; D003520:Cyclophosphamide; D001379:Azathioprine; D011241:Prednisone